Review



human retinal endothelial primary cell  (Celprogen Inc)


Bioz Verified Symbol Celprogen Inc is a verified supplier
Bioz Manufacturer Symbol Celprogen Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Celprogen Inc human retinal endothelial primary cell
    Human Retinal Endothelial Primary Cell, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human retinal endothelial primary cell/product/Celprogen Inc
    Average 94 stars, based on 1 article reviews
    human retinal endothelial primary cell - by Bioz Stars, 2026-03
    94/100 stars

    Images



    Similar Products

    93
    Innoprot Inc human primary retinal endothelial cells hrecs
    Human Primary Retinal Endothelial Cells Hrecs, supplied by Innoprot Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human primary retinal endothelial cells hrecs/product/Innoprot Inc
    Average 93 stars, based on 1 article reviews
    human primary retinal endothelial cells hrecs - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    94
    Celprogen Inc human retinal endothelial primary cell
    Human Retinal Endothelial Primary Cell, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human retinal endothelial primary cell/product/Celprogen Inc
    Average 94 stars, based on 1 article reviews
    human retinal endothelial primary cell - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    93
    Innoprot Inc primary retinal endothelial cells hrecs innoprot p10880 experimental models
    Primary Retinal Endothelial Cells Hrecs Innoprot P10880 Experimental Models, supplied by Innoprot Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary retinal endothelial cells hrecs innoprot p10880 experimental models/product/Innoprot Inc
    Average 93 stars, based on 1 article reviews
    primary retinal endothelial cells hrecs innoprot p10880 experimental models - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    Innoprot Inc human retinal endothelial cells
    Human Retinal Endothelial Cells, supplied by Innoprot Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human retinal endothelial cells/product/Innoprot Inc
    Average 93 stars, based on 1 article reviews
    human retinal endothelial cells - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    90
    ScienCell primary human retinal endothelial cells
    Effect of ranibizumab on the viability of adult retinal pigment epithelial 19 cells and human retinal microvascular <t>endothelial</t> cells. Cell viability was assessed using the Cell Counting Kit-8 assay ( n = 3, independent experiments). A: Effect of ranibizumab (0 mg/mL, 0.0625 mg/mL, 0.125 mg/mL, or 025 mg/mL) treatment on adult retinal pigment epithelial 19 (ARPE-19) cell viability; B: Effect of ranibizumab (0 mg/mL, 0.0625 mg/mL, 0.125 mg/mL, or 025 mg/mL) treatment on human retinal microvascular endothelial cell (HRMEC) viability. All results are expressed as the mean ± SD. d P < 0.0001. 1 P vs 24 hour group. 2 P vs 48 hour group. NC: Untreated group.
    Primary Human Retinal Endothelial Cells, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary human retinal endothelial cells/product/ScienCell
    Average 90 stars, based on 1 article reviews
    primary human retinal endothelial cells - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    CellSystems Biotechnologie Vertrieb GmbH primary human retinal microvascular endothelial cells (hrecs)
    Effect of ranibizumab on the viability of adult retinal pigment epithelial 19 cells and human retinal microvascular <t>endothelial</t> cells. Cell viability was assessed using the Cell Counting Kit-8 assay ( n = 3, independent experiments). A: Effect of ranibizumab (0 mg/mL, 0.0625 mg/mL, 0.125 mg/mL, or 025 mg/mL) treatment on adult retinal pigment epithelial 19 (ARPE-19) cell viability; B: Effect of ranibizumab (0 mg/mL, 0.0625 mg/mL, 0.125 mg/mL, or 025 mg/mL) treatment on human retinal microvascular endothelial cell (HRMEC) viability. All results are expressed as the mean ± SD. d P < 0.0001. 1 P vs 24 hour group. 2 P vs 48 hour group. NC: Untreated group.
    Primary Human Retinal Microvascular Endothelial Cells (Hrecs), supplied by CellSystems Biotechnologie Vertrieb GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary human retinal microvascular endothelial cells (hrecs)/product/CellSystems Biotechnologie Vertrieb GmbH
    Average 90 stars, based on 1 article reviews
    primary human retinal microvascular endothelial cells (hrecs) - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    93
    Innoprot Inc primary human retinal microvascular endothelial cells hrmecs
    Effect of ranibizumab on the viability of adult retinal pigment epithelial 19 cells and human retinal microvascular <t>endothelial</t> cells. Cell viability was assessed using the Cell Counting Kit-8 assay ( n = 3, independent experiments). A: Effect of ranibizumab (0 mg/mL, 0.0625 mg/mL, 0.125 mg/mL, or 025 mg/mL) treatment on adult retinal pigment epithelial 19 (ARPE-19) cell viability; B: Effect of ranibizumab (0 mg/mL, 0.0625 mg/mL, 0.125 mg/mL, or 025 mg/mL) treatment on human retinal microvascular endothelial cell (HRMEC) viability. All results are expressed as the mean ± SD. d P < 0.0001. 1 P vs 24 hour group. 2 P vs 48 hour group. NC: Untreated group.
    Primary Human Retinal Microvascular Endothelial Cells Hrmecs, supplied by Innoprot Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary human retinal microvascular endothelial cells hrmecs/product/Innoprot Inc
    Average 93 stars, based on 1 article reviews
    primary human retinal microvascular endothelial cells hrmecs - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    Innoprot Inc primary human retinal endothelial cells
    Effect of ranibizumab on the viability of adult retinal pigment epithelial 19 cells and human retinal microvascular <t>endothelial</t> cells. Cell viability was assessed using the Cell Counting Kit-8 assay ( n = 3, independent experiments). A: Effect of ranibizumab (0 mg/mL, 0.0625 mg/mL, 0.125 mg/mL, or 025 mg/mL) treatment on adult retinal pigment epithelial 19 (ARPE-19) cell viability; B: Effect of ranibizumab (0 mg/mL, 0.0625 mg/mL, 0.125 mg/mL, or 025 mg/mL) treatment on human retinal microvascular endothelial cell (HRMEC) viability. All results are expressed as the mean ± SD. d P < 0.0001. 1 P vs 24 hour group. 2 P vs 48 hour group. NC: Untreated group.
    Primary Human Retinal Endothelial Cells, supplied by Innoprot Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary human retinal endothelial cells/product/Innoprot Inc
    Average 93 stars, based on 1 article reviews
    primary human retinal endothelial cells - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    90
    Neuromics primary human retinal microvascular endothelial cells
    Effect of ranibizumab on the viability of adult retinal pigment epithelial 19 cells and human retinal microvascular <t>endothelial</t> cells. Cell viability was assessed using the Cell Counting Kit-8 assay ( n = 3, independent experiments). A: Effect of ranibizumab (0 mg/mL, 0.0625 mg/mL, 0.125 mg/mL, or 025 mg/mL) treatment on adult retinal pigment epithelial 19 (ARPE-19) cell viability; B: Effect of ranibizumab (0 mg/mL, 0.0625 mg/mL, 0.125 mg/mL, or 025 mg/mL) treatment on human retinal microvascular endothelial cell (HRMEC) viability. All results are expressed as the mean ± SD. d P < 0.0001. 1 P vs 24 hour group. 2 P vs 48 hour group. NC: Untreated group.
    Primary Human Retinal Microvascular Endothelial Cells, supplied by Neuromics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary human retinal microvascular endothelial cells/product/Neuromics
    Average 90 stars, based on 1 article reviews
    primary human retinal microvascular endothelial cells - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    93
    Innoprot Inc primary human retinal microvascular endothelial cells hrec
    Effect of ranibizumab on the viability of adult retinal pigment epithelial 19 cells and human retinal microvascular <t>endothelial</t> cells. Cell viability was assessed using the Cell Counting Kit-8 assay ( n = 3, independent experiments). A: Effect of ranibizumab (0 mg/mL, 0.0625 mg/mL, 0.125 mg/mL, or 025 mg/mL) treatment on adult retinal pigment epithelial 19 (ARPE-19) cell viability; B: Effect of ranibizumab (0 mg/mL, 0.0625 mg/mL, 0.125 mg/mL, or 025 mg/mL) treatment on human retinal microvascular endothelial cell (HRMEC) viability. All results are expressed as the mean ± SD. d P < 0.0001. 1 P vs 24 hour group. 2 P vs 48 hour group. NC: Untreated group.
    Primary Human Retinal Microvascular Endothelial Cells Hrec, supplied by Innoprot Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary human retinal microvascular endothelial cells hrec/product/Innoprot Inc
    Average 93 stars, based on 1 article reviews
    primary human retinal microvascular endothelial cells hrec - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    Image Search Results


    Effect of ranibizumab on the viability of adult retinal pigment epithelial 19 cells and human retinal microvascular endothelial cells. Cell viability was assessed using the Cell Counting Kit-8 assay ( n = 3, independent experiments). A: Effect of ranibizumab (0 mg/mL, 0.0625 mg/mL, 0.125 mg/mL, or 025 mg/mL) treatment on adult retinal pigment epithelial 19 (ARPE-19) cell viability; B: Effect of ranibizumab (0 mg/mL, 0.0625 mg/mL, 0.125 mg/mL, or 025 mg/mL) treatment on human retinal microvascular endothelial cell (HRMEC) viability. All results are expressed as the mean ± SD. d P < 0.0001. 1 P vs 24 hour group. 2 P vs 48 hour group. NC: Untreated group.

    Journal: World Journal of Diabetes

    Article Title: Effect of ranibizumab on diabetic retinopathy via the vascular endothelial growth factor/STAT3/glial fibrillary acidic protein pathway

    doi: 10.4239/wjd.v16.i5.99473

    Figure Lengend Snippet: Effect of ranibizumab on the viability of adult retinal pigment epithelial 19 cells and human retinal microvascular endothelial cells. Cell viability was assessed using the Cell Counting Kit-8 assay ( n = 3, independent experiments). A: Effect of ranibizumab (0 mg/mL, 0.0625 mg/mL, 0.125 mg/mL, or 025 mg/mL) treatment on adult retinal pigment epithelial 19 (ARPE-19) cell viability; B: Effect of ranibizumab (0 mg/mL, 0.0625 mg/mL, 0.125 mg/mL, or 025 mg/mL) treatment on human retinal microvascular endothelial cell (HRMEC) viability. All results are expressed as the mean ± SD. d P < 0.0001. 1 P vs 24 hour group. 2 P vs 48 hour group. NC: Untreated group.

    Article Snippet: Human retinal microvascular endothelial cells (HRMECs) and primary human retinal endothelial cells were purchased from ScienCell (Carlsbad, CA, United States) and cultured in a low-glucose (5.5 mmol/L) primary endothelial cell culture medium (ScienCell, Wuhan, Hubei Province, China) in a humidified atmosphere containing 50 mL/L carbon dioxide at 37 °C.

    Techniques: Cell Counting

    mRNA expression of vascular endothelial growth factor, interleukin 6, cluster of differentiation 18, intercellular adhesion molecule, tumor necrosis factor alpha, and signal transducer and activator of transcription 3 in adult retinal pigment epithelial 19 cells and human retinal microvascular endothelial cells. Untreated (NC) (5.5 mmol/L glucose), NC + ranibizumab (5.5 mmol/L glucose + 0.125 mg/mL ranibizumab), high glucose (Hg) (25 mmol/L glucose), and Hg + ranibizumab (25 mmol/L glucose + 0.125 mg/mL ranibizumab). A: Ratios of the mRNA expression of vascular endothelial growth factor (VEGF), interleukin 6 (IL-6), cluster of 18 differentiation (CD18), intercellular adhesion molecule (ICAM), tumor necrosis factor alpha (TNF-α), and signal transducer and activator of transcription 3 (STAT3) in different adult retinal pigment epithelial 19 (ARPE-19) groups; B: Ratios of mRNA expression of VEGF, IL-6, CD18, ICAM, TNF-α, and STAT3 in different human retinal microvascular endothelial cell (HRMEC) groups. All results are expressed as the mean ± SD. a P < 0.05. b P < 0.01. 1 P vs NC group. 2 P vs Hg group.

    Journal: World Journal of Diabetes

    Article Title: Effect of ranibizumab on diabetic retinopathy via the vascular endothelial growth factor/STAT3/glial fibrillary acidic protein pathway

    doi: 10.4239/wjd.v16.i5.99473

    Figure Lengend Snippet: mRNA expression of vascular endothelial growth factor, interleukin 6, cluster of differentiation 18, intercellular adhesion molecule, tumor necrosis factor alpha, and signal transducer and activator of transcription 3 in adult retinal pigment epithelial 19 cells and human retinal microvascular endothelial cells. Untreated (NC) (5.5 mmol/L glucose), NC + ranibizumab (5.5 mmol/L glucose + 0.125 mg/mL ranibizumab), high glucose (Hg) (25 mmol/L glucose), and Hg + ranibizumab (25 mmol/L glucose + 0.125 mg/mL ranibizumab). A: Ratios of the mRNA expression of vascular endothelial growth factor (VEGF), interleukin 6 (IL-6), cluster of 18 differentiation (CD18), intercellular adhesion molecule (ICAM), tumor necrosis factor alpha (TNF-α), and signal transducer and activator of transcription 3 (STAT3) in different adult retinal pigment epithelial 19 (ARPE-19) groups; B: Ratios of mRNA expression of VEGF, IL-6, CD18, ICAM, TNF-α, and STAT3 in different human retinal microvascular endothelial cell (HRMEC) groups. All results are expressed as the mean ± SD. a P < 0.05. b P < 0.01. 1 P vs NC group. 2 P vs Hg group.

    Article Snippet: Human retinal microvascular endothelial cells (HRMECs) and primary human retinal endothelial cells were purchased from ScienCell (Carlsbad, CA, United States) and cultured in a low-glucose (5.5 mmol/L) primary endothelial cell culture medium (ScienCell, Wuhan, Hubei Province, China) in a humidified atmosphere containing 50 mL/L carbon dioxide at 37 °C.

    Techniques: Expressing

    Expression of glial fibrillary acidic protein, signal transducer and activator of transcription 3 (STAT3), and phosphorylated STAT3 proteins in adult retinal pigment epithelial 19 cells and human retinal microvascular endothelial cells. Untreated (NC) (5.5 mmol/L glucose), NC + ranibizumab (5.5 mmol/L glucose + 0.125 mg/mL ranibizumab), high glucose (Hg) (25 mmol/L glucose), and Hg + ranibizumab (25 mmol/L glucose + 0.125 mg/mL ranibizumab). A: Expression of glial fibrillary acidic protein (GFAP), signal transducer and activator of transcription 3 (STAT3), and phosphorylated STAT3 (pSTAT3) proteins in adult retinal pigment epithelial 19 (ARPE-19) cells were detected by Western blot analysis; B: Expression of GFAP, STAT3, and pSTAT3 proteins in human retinal microvascular endothelial cells (HRMECs) were detected by Western blot analysis; C: Ratios of GFAP, STAT3, and pSTAT3 protein expression levels in different groups of ARPE-19 cells; D: Ratios of GFAP, STAT3, and pSTAT3 protein expression levels in different groups of HRMECs. All results are expressed as the mean ± SD. a P < 0.05. b P < 0.01. 1 P vs NC group. 2 P vs Hg group.

    Journal: World Journal of Diabetes

    Article Title: Effect of ranibizumab on diabetic retinopathy via the vascular endothelial growth factor/STAT3/glial fibrillary acidic protein pathway

    doi: 10.4239/wjd.v16.i5.99473

    Figure Lengend Snippet: Expression of glial fibrillary acidic protein, signal transducer and activator of transcription 3 (STAT3), and phosphorylated STAT3 proteins in adult retinal pigment epithelial 19 cells and human retinal microvascular endothelial cells. Untreated (NC) (5.5 mmol/L glucose), NC + ranibizumab (5.5 mmol/L glucose + 0.125 mg/mL ranibizumab), high glucose (Hg) (25 mmol/L glucose), and Hg + ranibizumab (25 mmol/L glucose + 0.125 mg/mL ranibizumab). A: Expression of glial fibrillary acidic protein (GFAP), signal transducer and activator of transcription 3 (STAT3), and phosphorylated STAT3 (pSTAT3) proteins in adult retinal pigment epithelial 19 (ARPE-19) cells were detected by Western blot analysis; B: Expression of GFAP, STAT3, and pSTAT3 proteins in human retinal microvascular endothelial cells (HRMECs) were detected by Western blot analysis; C: Ratios of GFAP, STAT3, and pSTAT3 protein expression levels in different groups of ARPE-19 cells; D: Ratios of GFAP, STAT3, and pSTAT3 protein expression levels in different groups of HRMECs. All results are expressed as the mean ± SD. a P < 0.05. b P < 0.01. 1 P vs NC group. 2 P vs Hg group.

    Article Snippet: Human retinal microvascular endothelial cells (HRMECs) and primary human retinal endothelial cells were purchased from ScienCell (Carlsbad, CA, United States) and cultured in a low-glucose (5.5 mmol/L) primary endothelial cell culture medium (ScienCell, Wuhan, Hubei Province, China) in a humidified atmosphere containing 50 mL/L carbon dioxide at 37 °C.

    Techniques: Expressing, Western Blot

    Ratio between the endothelial cell to pericyte ratio and the number of acellular strands. A: Ratio between the endothelial cell to pericyte (E/P) ratio and the number of acellular strands in each group revealed by retinal periodic acid-Schiff staining (magnification: 400 ×; scale bar: 2.5 μm); B and C: Ratio between E/P and the number of acellular strands during the sixth, eighth, and tenth weeks. The yellow arrows indicate the acellular strands, while the orange arrows indicate neovascularization bud. All results are expressed as the mean ± SD. a P < 0.05. b P < 0.01. 1 P vs F group. 2 P vs B group. 3 P vs D group.

    Journal: World Journal of Diabetes

    Article Title: Effect of ranibizumab on diabetic retinopathy via the vascular endothelial growth factor/STAT3/glial fibrillary acidic protein pathway

    doi: 10.4239/wjd.v16.i5.99473

    Figure Lengend Snippet: Ratio between the endothelial cell to pericyte ratio and the number of acellular strands. A: Ratio between the endothelial cell to pericyte (E/P) ratio and the number of acellular strands in each group revealed by retinal periodic acid-Schiff staining (magnification: 400 ×; scale bar: 2.5 μm); B and C: Ratio between E/P and the number of acellular strands during the sixth, eighth, and tenth weeks. The yellow arrows indicate the acellular strands, while the orange arrows indicate neovascularization bud. All results are expressed as the mean ± SD. a P < 0.05. b P < 0.01. 1 P vs F group. 2 P vs B group. 3 P vs D group.

    Article Snippet: Human retinal microvascular endothelial cells (HRMECs) and primary human retinal endothelial cells were purchased from ScienCell (Carlsbad, CA, United States) and cultured in a low-glucose (5.5 mmol/L) primary endothelial cell culture medium (ScienCell, Wuhan, Hubei Province, China) in a humidified atmosphere containing 50 mL/L carbon dioxide at 37 °C.

    Techniques: Staining

    mRNA expression of vascular endothelial growth factor, interleukin 6, cluster of differentiation 18, intercellular adhesion molecule, tumor necrosis factor-alpha, and signal transducer and activator of transcription 3 in the retinal tissues of Sprague-Dawley rats. A: Ratio of vascular endothelial growth factor (VEGF) mRNA expression in the retinal tissue of each group of Sprague-Dawley (SD) rats; B: Ratio of interleukin 6 (IL-6) mRNA expression in the retinal tissue of each group of SD rats; C: Ratio of cluster of differentiation 18 (CD18) mRNA expression in the retinal tissue of each group of SD rats; D: Ratio of intercellular adhesion molecule (ICAM) mRNA expression in the retinal tissue of each group of rats; E: Ratio of tumor necrosis factor alpha (TNF-a) mRNA expression in the retinal tissue of each group of rats; F: Ratio of signal transducer and activator of transcription 3 (STAT3) mRNA expression in the retinal tissue of each group of rats. All results are expressed as the mean ± SD. a P < 0.05. b P < 0.01. 1 P vs A group. 2 P vs B group. 3 P vs C group. 4 P vs D group. 5 P vs F group.

    Journal: World Journal of Diabetes

    Article Title: Effect of ranibizumab on diabetic retinopathy via the vascular endothelial growth factor/STAT3/glial fibrillary acidic protein pathway

    doi: 10.4239/wjd.v16.i5.99473

    Figure Lengend Snippet: mRNA expression of vascular endothelial growth factor, interleukin 6, cluster of differentiation 18, intercellular adhesion molecule, tumor necrosis factor-alpha, and signal transducer and activator of transcription 3 in the retinal tissues of Sprague-Dawley rats. A: Ratio of vascular endothelial growth factor (VEGF) mRNA expression in the retinal tissue of each group of Sprague-Dawley (SD) rats; B: Ratio of interleukin 6 (IL-6) mRNA expression in the retinal tissue of each group of SD rats; C: Ratio of cluster of differentiation 18 (CD18) mRNA expression in the retinal tissue of each group of SD rats; D: Ratio of intercellular adhesion molecule (ICAM) mRNA expression in the retinal tissue of each group of rats; E: Ratio of tumor necrosis factor alpha (TNF-a) mRNA expression in the retinal tissue of each group of rats; F: Ratio of signal transducer and activator of transcription 3 (STAT3) mRNA expression in the retinal tissue of each group of rats. All results are expressed as the mean ± SD. a P < 0.05. b P < 0.01. 1 P vs A group. 2 P vs B group. 3 P vs C group. 4 P vs D group. 5 P vs F group.

    Article Snippet: Human retinal microvascular endothelial cells (HRMECs) and primary human retinal endothelial cells were purchased from ScienCell (Carlsbad, CA, United States) and cultured in a low-glucose (5.5 mmol/L) primary endothelial cell culture medium (ScienCell, Wuhan, Hubei Province, China) in a humidified atmosphere containing 50 mL/L carbon dioxide at 37 °C.

    Techniques: Expressing